Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;18(2):237-244.
doi: 10.1177/1740774520982315. Epub 2021 Jan 10.

Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout

Affiliations

Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout

Shana D Stites et al. Clin Trials. 2021 Apr.

Abstract

Background: Missing data are a notable problem in Alzheimer's disease clinical trials. One cause of missing data is participant dropout. The Research Attitudes Questionnaire is a 7-item instrument that measures an individual's attitudes toward biomedical research, with higher scores indicating more favorable attitudes. The objective of this study was to describe the performance of the Research Attitudes Questionnaire over time and to examine whether Research Attitudes Questionnaire scores predict study dropout and other participant behaviors that affect trial integrity.

Methods: The Research Attitudes Questionnaire was collected at baseline and weeks 26 and 52 from each member of 119 participant/study partner dyads enrolled in a Phase 2, randomized, double-blind, placebo-controlled mild-to-moderate Alzheimer's disease clinical trial. Within-subject longitudinal analyses examined change in Research Attitudes Questionnaire scores over time in each population. Logistic regression analyses that controlled for trial arm and clustering in trial sites were used to assess whether baseline Research Attitudes Questionnaire scores predicted trial completion, study medication compliance, and enrollment in optional substudies.

Results: Participants and study partners endorsed statistically similar ratings on the Research Attitudes Questionnaire that were stable over time. Participants with baseline Research Attitudes Questionnaire scores above 28.5 were 4.7 (95% confidence interval = 1.01 to 21.95) times as likely to complete the trial compared to those with lower scores. Applying the same cutoff, baseline study partner Research Attitudes Questionnaire scores were similarly able to predict study completion (odds ratio = 4.2, 95% confidence interval = 1.71 to 10.32). Using a score cutoff of 27.5, higher participant Research Attitudes Questionnaire scores predicted study medication compliance (odds ratio = 5.85, 95% confidence interval = 1.34 to 25.54). No relationship was observed between Research Attitudes Questionnaire score and participation in optional substudies.

Conclusion: This brief instrument that measures research attitudes may identify participants at risk for behaviors that cause missing data.

Trial registration: ClinicalTrials.gov NCT01504854.

Keywords: Dropout; missingness; retention.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scatterplot of participant and study partner baseline RAQ scores (N=119)

Similar articles

Cited by

References

    1. Angst J, Bech P, Bobon D, et al. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs. Pharmacopsychiatry 1991; 24: 149–152. 1991/September/01. - PubMed
    1. Gross RA and Johnston KC. Levels of evidence: Taking Neurology to the next level. Neurology 2009; 72: 8–10. - PubMed
    1. Gardette V, Coley N, Toulza O, et al. Attrition in geriatric research: how important is it and how should it be dealt with? The journal of nutrition, health & aging 2007; 11: 265–271. - PubMed
    1. Bynum JPW, Rabins PV, Weller W, et al. The Relationship Between a Dementia Diagnosis, Chronic Illness, Medicare Expenditures, and Hospital Use. Journal of the American Geriatrics Society 2004; 52: 187–194. DOI: 10.1111/j.1532-5415.2004.52054.x. - DOI - PubMed
    1. Schneider LS and Sano M. Current Alzheimer's disease clinical trials: methods and placebo outcomes. Alzheimers Dement 2009; 5: 388–397. - PMC - PubMed

Publication types

Associated data